References:
1. National Research Council: Iron. Recommended Dietary Allowances, 10th ed. National Academy Press, Washington, DC; 1998.
2. Campbell NRC, Campbell RRA & Hasinoff BB: Ferrous sulfate reduces methyldopa absorption: methyldopa: iron complex formation as a likely mechanism. Clin Invest Med 1990; 13:329-332.
3. Cook JD, Dassenko SA & Whittaker P: Calcium supplementation: effect on iron absorption. Am J Clin Nutr 1991; 53(1): 106-111.
4. Scott JL, Finegold SM, Belkin GA et al: A controlled, double-blind study of the hematologic toxicity of chloramphenicol. N Engl J Med 1965; 272(22): 1137-1142.
5. Daoud AS, Batieha A, Al-Sheyyab M et al:Effectiveness of iron therapy on breath-holding spells. J Pediatr 1997; 130:547-550.
6. Bruner AB, Joffe A & Duffan AK: Randomized study of cognitive effects of iron supplementation in non-anemic iron-deficient adolescent girls. Lancet 1996; 348:992-996.
7. Couper RTL & Simmer KN: Iron deficiency in children: food for thought. Med J Australia 2001; 174(4):162-163.
8. Johnson KB: The Harriet Lane Handbook, 13th ed. Mosby-Year Book, Inc, St Louis, MO, USA; 1993: 194-195.
9. Baker WF: Iron deficiency in pregnancy, obstretics, and gynecology. Hematol Oncol Clin North Am 2000; 14(5): 1061-1077.
10. Camitta BM & Nathan DG: Anemia in adolescence: I. Disturbances of iron balance. Postgrad Med 1975; 57(2):143-146.
11. Product Information: Slow FE(R), iron. CIBA Consumer, Summit, NJ, USA; 1996.
12. Beard J, Borel M & Peterson FJ: Changes in iron status during weight loss with very-low-energy diets. Am J Clin Nutr 1997; 66:104-110.
13. Hoffman RM & Jaffe PE: Plummer-Vinson syndrome: a case report and literature review. Arch Intern Med 1995; 155(18):2008-2011.
14. Milman N, Bergholt T, Byg KE et al: Iron status and iron balance during pregnancy. A critical reappraisal of iron supplementation. Acta Obstet Gynecol Scand 1999; 78(9):749-757.
15. Groner JA, Holtzman NA, Charney E et al: A randomized trial of oral iron on tests of short-term memory and attention span in young pregnant women. J Adolesc Health Care 1986; 7(1):44-48.
16. Hansten PD: Drug Interactions, 5th ed. Lea & Febiger, Philadelphia, PA, USA, 1985.
17. Das KM & Eastwood MA: Effect of iron and calcium on salicylazosulphapyridine metabolism. Scand Med J 1973; 18:45-50.
18. Product Information: Prilosec(R), omeprazole. Astra Merck Inc., Wayne, PA, 1995.
19. Venho VM, Salonen RO & Mattila MJ: Modification of the pharmacokinetics of doxycycline in man by ferrous sulfate or charcoal. Eur J Clin Pharmacol 1978; 14:277-280.
20. Leonard JP, Desager JP, Beckers C et al: In vitro binding of various biological substances by two hypocholesterolaemic resins, cholestyramine and colestipol. Arzneimittelforschung 1979; 29:979-981.
21. Cook JD, Reddy MB & Hurrell RF: The effect of red and white wines on nonheme-iron absorption in humans. Am J Clin Nutr 1995; 61:800-804.
22. Schaefer JP, Tam Y, Hasinoff BB et al: Ferrous sulphate interacts with captopril. Br J Clin Pharmacol 1998; 46:377-381.
23. Campbell NR, Hasinoff BB, Stalts H et al: Ferrous sulfate reduces thyroxine efficacy in patients with hypthyroidism. Ann Intern Med 1992; 117:1010-1013.
24. Pizarro F, Olivares M, Hertrampf E, Walter T (1994). Factors which modify the nutritional state of iron: tannin content of herbal teas. Arch Latinoam Nutr 44:277-80.
25. Product Information: Syprine(R), trientine hydrochloride. Merck & Co., Inc., West Point, PA, 1997.
26. Morii M, Ueno K, Ogawa A et al: Impairment of mycophenolate mofetil absorption by iron ion. Clin Pharmacol Ther 2000; 68:613-616.
27. Herman DL & Smith FH: Effect of bound gossypol on the absorption of iron by rats. J Nutr 1973; 103(6):882-889.
28. Product Information: Didronel(R), etidronate disodium. Procter & Gamble Pharmaceuticals, Inc., Cincinnati, OH, 1998.
29. Muijsers AO, vand de Stadt RJ, Henrichs AM et al: D-penicillamine in patients with rheumatoid arthritis: serum levels, pharmacokinetics aspects, and correlation with clinical course and side effects.Arthritis Rheum 1984; 27(12):1362-1369.
30. Gabrielli GB & De Sandre G: Excessive tea consumption can inhibit the efficacy of oral iron treatment in iron-deficiency anemia. Haematologica 1995; 80(6):518-520.
31. Hallberg L & Rossander L: Effect of different drinks on the absorption of non-heme iron from composite meals. Hum Nutr Appl Nutr 1982; 36(2):116-123.
32. Product Information: Prevacid(R), lansoprazole. TAP Pharmaceuticals, Lake Forest, IL (PI revised 8/2002) reviewed 10/2002.
33. Product Information: Aciphex(R), rabeprazole sodium. Eisai Co., Ltd., Tokyo, Japan, 2002.
34. Product Information: PROMACTA(R) oral tablets, eltrombopag oral tablets. Glaxo Smith Kline, Research Triangle Park, NC, 2008.